Antimicrobial resistance (AMR) is a critical global health concern under the present clinical scenario due to the overuse and misuse of antibiotics in both medical and agricultural sectors. Passiflora foetida, commonly known as wild maracuja or stinking passion flower belongs to the Passifloraceae family and is native to tropical and subtropical regions of Asia, Africa, Australia, and America. In this study, we aimed to explore the potential antimicrobial efficacy of Passiflora foetida leaf extract against both MDR bacteria and American Type Culture Collection (ATCC) strains for possible combating microbial infections in the future. The MIC value of Passiflora foetida extract varied between 5-10 mg/ml in different ATCC and MDR bacteria studied in this experiment. Passiflora foetida is also well known in traditional medicine indicating a degree of safety and efficacy, although modern scientific validation is necessary to support its therapeutic applications. Future research should focus on identifying the specific bioactive agent responsible for its antimicrobial effects, optimizing extraction methods to maximize bioavailability, and evaluating its safety and efficacy in animal models and clinical trials. Understanding the antimicrobial properties of Passiflora foetida is crucial for developing effective therapeutic strategies against antibiotic-resistant infections. By harnessing the natural antimicrobial potential of this plant, researchers may uncover new treatment options to combat AMR and improve patient outcomes. The findings of this study indicated its possible use as a topical application at present till further study with refined extract may reveal its application in vivo in different diseases with MDR microorganisms.